Evidence map›Paper›PMID 24062438›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes.

Toshi Shioda, Noël F Rosenthal, Kathryn R Coser, Mizuki Suto, Mukta Phatak, Mario Medvedovic, Vincent J Carey, Kurt J Isselbacher

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Dose- and Time-Dependent Transcriptional Response of Ishikawa Cells Exposed to Genistein.Toxicological sciences : an official journal of the Society of Toxicology · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. A path forward in the debate over health impacts of endocrine disrupting chemicals.Environmental health : a global access science source · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Toshi ShiodaMolecular Profiling Laboratory, Massachusetts General Hospital Center for Cancer Research, Charlestown, MA 02129.
Noël F Rosenthal
Kathryn R Coser
Mizuki Suto
Mukta Phatak
Mario Medvedovic
Vincent J Carey
Kurt J Isselbacher
Harvard University · USUniversity of Cincinnati Medical Center · USCenter for Cancer Research · USMassachusetts General Hospital · US

Funding

Project-002U41HG004059 · NHGRI · ROSWELL PARK CANCER INSTITUTE CORP · PI MORGAN, MARTIN T · 2011 to 2020
$13.2M
Genetics and Gene Expression Profiling in AsthmaR01HL086601 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI RABY, BENJAMIN ALEXANDER · 2007 to 2015
$6.8M
NHGRI NIH HHS U41 HG004059NHGRI NIH HHS U41-HG004059NHLBI NIH HHS R01 HL086601NHLBI NIH HHS R01-HL086601
6 · The paper itself

Abstract

Although biological effects of endocrine disrupting chemicals (EDCs) are often observed at unexpectedly low doses with occasional nonmonotonic dose-response characteristics, transcriptome-wide profiles of sensitivities or dose-dependent behaviors of the EDC responsive genes have remained unexplored. Here, we describe expressome analysis for the comprehensive examination of dose-dependent gene responses and its applications to characterize estrogen responsive genes in MCF-7 cells. Transcriptomes of MCF-7 cells exposed to varying concentrations of representative natural and xenobiotic estrogens for 48 h were determined by microarray and used for computational calculation of interpolated approximations of estimated transcriptomes for 300 doses uniformly distributed in log space for each chemical. The entire collection of these estimated transcriptomes, designated as the expressome, has provided unique opportunities to profile chemical-specific distributions of ligand sensitivities for large numbers of estrogen responsive genes, revealing that at low concentrations estrogens generally tended to suppress rather than to activate transcription. Gene ontology analysis demonstrated distinct functional enrichment between high- and low-sensitivity estrogen responsive genes, supporting the notion that a single EDC chemical can cause qualitatively distinct biological responses at different doses. Expressomal heatmap visualization of dose-dependent induction of Bisphenol A inducible genes showed a weak gene activation peak at a very low concentration range (ca. 0.1 nM) in addition to the main, strong gene activation peak at and above 100 nM. Thus, expressome analysis is a powerful approach to understanding the EDC dose-dependent dynamic changes in gene expression at the transcriptomal level, providing important information on the overall profiles of ligand sensitivities and nonmonotonic responses.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsDose-Response Relationship, DrugEndocrine DisruptorsEstrogensGene Expression ProfilingGene Expression RegulationGene OntologyHumansMCF-7 CellsMicroarray AnalysisPhenolsRNA, MessengerBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsEstrogensPhenolsRNA, Messenger

Identifiers

PMID24062438
PMCPMC3799318
OpenAlexW1992427783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.